Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +1.1% | +4.3% | +12.7% | −13.0% | +13.7% | +31.0% | +136.6% | +22.1% | +154.6% |
| Peer average | +0.3% | −0.5% | +8.6% | +5.8% | +23.7% | +32.3% | +74.0% | +27.4% | — |
| S&P 500 · VOO | +1.3% | −0.9% | −2.4% | −2.1% | +12.3% | +12.8% | +81.3% | +75.3% | — |
$46 of every $1,000 in SBIO is Oruka
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ORKAOruka Therapeutics | Healthcare | 4.60% | $460.35 | 81K | $8.9M |
| 2 | CGONCG oncology | Healthcare | 4.09% | $408.55 | 108K | $7.9M |
| 3 | MANEVeraDermics | Healthcare | 3.94% | $394.16 | 51K | $7.6M |
| 4 | EWTXEdgewise Therapeutics | Healthcare | 3.21% | $320.64 | 133K | $6.2M |
| 5 | DNTHDianthus Therapeutics | Healthcare | 3.16% | $315.60 | 68K | $6.1M |
| 6 | TVTXTravere Therapeutics | Healthcare | 3.11% | $310.68 | 115K | $6.0M |
| 7 | DFTXDefinium Therapeutics | Healthcare | 2.95% | $295.27 | 164K | $5.7M |
| 8 | RLAYRelay Therapeutics | Healthcare | 2.78% | $277.71 | 268K | $5.3M |
| 9 | XENEXenon Pharmaceuticals | Healthcare | 2.55% | $254.72 | 119K | $4.9M |
| 10 | AMLXAmylyx Pharmaceuticals | Healthcare | 2.47% | $246.61 | 154K | $4.8M |
| 11 | VRDNViridian Therapeutics | Healthcare | 2.22% | $222.17 | 139K | $4.3M |
| 12 | DYNDyne Therapeutics | Healthcare | 2.13% | $212.68 | 229K | $4.1M |
| 13 | IRONDisc Medicine | Healthcare | 2.06% | $206.47 | 47K | $4.0M |
| 14 | TARSTarsus Pharmaceuticals | Healthcare | 2.06% | $205.87 | 54K | $4.0M |
| 15 | DNLIDenali Therapeutics | Healthcare | 2.02% | $201.66 | 196K | $3.9M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics | 4.60% |
| 2 | CGON | CG oncology | 4.09% |
| 3 | MANE | VeraDermics | 3.94% |
| 4 | EWTX | Edgewise Therapeutics | 3.21% |
| 5 | DNTH | Dianthus Therapeutics | 3.16% |
| 6 | TVTX | Travere Therapeutics | 3.11% |
| 7 | DFTX | Definium Therapeutics | 2.95% |
| 8 | RLAY | Relay Therapeutics | 2.78% |
| 9 | XENE | Xenon Pharmaceuticals | 2.55% |
| 10 | AMLX | Amylyx Pharmaceuticals | 2.47% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2024 | Dec 26, 2024 | $1.17 |
| Dec 21, 2023 | Dec 27, 2023 | $0.0711 |
| Dec 19, 2019 | Dec 27, 2019 | $0.0160 |
| Dec 20, 2018 | Dec 27, 2018 | $0.78 |
| Dec 21, 2017 | Dec 28, 2017 | $0.58 |